Regorafenib treatment outcome for Taiwanese patients with metastatic gastrointestinal stromal tumors after failure of imatinib and sunitinib: A prospective, non-randomized, single-center study

The present study aimed to conduct a prognosis analysis of Taiwanese patients with metastatic gastrointestinal stromal tumors (GISTs), who are resistant to or were unable to tolerate imatinib or sunitinib, and were subsequently treated with regorafenib. The study considered the survival, potential p...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Chia-Hsiang, Yeh, Chun-Nan, Chen, Jen-Shi, Tsai, Chun-Yi, Wang, Shang-Yu, Cheng, Chi-Tung, Yeh, Ta-Sen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7400021/
https://www.ncbi.nlm.nih.gov/pubmed/32782530
http://dx.doi.org/10.3892/ol.2020.11756

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7400021/
https://www.ncbi.nlm.nih.gov/pubmed/32782530
http://dx.doi.org/10.3892/ol.2020.11756

Ejemplares similares